Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Cresco Labs' Share-based Compensation fell 1719.81% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.3 million, marking a year-over-year decrease of 1625.85%. This contributed to the annual value of $14.2 million for FY2024, which is 1340.18% down from last year.
  • According to the latest figures from Q3 2025, Cresco Labs' Share-based Compensation is $2.3 million, which was down 1719.81% from $2.5 million recorded in Q2 2025.
  • Cresco Labs' 5-year Share-based Compensation high stood at $9.5 million for Q2 2021, and its period low was $2.2 million during Q2 2023.
  • Its 5-year average for Share-based Compensation is $4.7 million, with a median of $4.1 million in 2023.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 19483.57% in 2021, then plummeted by 7039.87% in 2023.
  • Cresco Labs' Share-based Compensation (Quarter) stood at $4.9 million in 2021, then rose by 6.87% to $5.3 million in 2022, then tumbled by 42.76% to $3.0 million in 2023, then increased by 22.8% to $3.7 million in 2024, then plummeted by 37.62% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $2.5 million for Q2 2025, and $2.7 million during Q1 2025.